558 related articles for article (PubMed ID: 9143708)
21. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
Adams S; Humphreys RE
Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
[TBL] [Abstract][Full Text] [Related]
22. Rapid constitutive generation of a specific peptide-MHC class II complex from intact exogenous protein in immature murine dendritic cells.
Colledge L; Bennett CL; Reay PA; Blackburn CC
Eur J Immunol; 2002 Nov; 32(11):3246-55. PubMed ID: 12555670
[TBL] [Abstract][Full Text] [Related]
23. Peptide exchange in MHC molecules.
Jensen PE; Weber DA; Thayer WP; Westerman LE; Dao CT
Immunol Rev; 1999 Dec; 172():229-38. PubMed ID: 10631949
[TBL] [Abstract][Full Text] [Related]
24. Regulation of MHC II and CD1 antigen presentation: from ubiquity to security.
Gelin C; Sloma I; Charron D; Mooney N
J Leukoc Biol; 2009 Feb; 85(2):215-24. PubMed ID: 18809734
[TBL] [Abstract][Full Text] [Related]
25. Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells.
von Delwig A; Musson JA; Gray J; McKie N; Robinson JH
Immunology; 2005 Feb; 114(2):194-203. PubMed ID: 15667564
[TBL] [Abstract][Full Text] [Related]
26. CD1 and MHC II find different means to the same end.
Sullivan BA; Nagarajan NA; Kronenberg M
Trends Immunol; 2005 May; 26(5):282-8. PubMed ID: 15866242
[TBL] [Abstract][Full Text] [Related]
27. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
[TBL] [Abstract][Full Text] [Related]
29. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.
Shen Z; Reznikoff G; Dranoff G; Rock KL
J Immunol; 1997 Mar; 158(6):2723-30. PubMed ID: 9058806
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of lipid antigen presentation by CD1.
Jackman RM; Moody DB; Porcelli SA
Crit Rev Immunol; 1999; 19(1):49-63. PubMed ID: 9987600
[TBL] [Abstract][Full Text] [Related]
31. Intracellular transport of MHC class II molecules.
Neefjes JJ; Ploegh HL
Immunol Today; 1992 May; 13(5):179-84. PubMed ID: 1642756
[TBL] [Abstract][Full Text] [Related]
32. Assembly, transport, and function of MHC class II molecules.
Cresswell P
Annu Rev Immunol; 1994; 12():259-93. PubMed ID: 8011283
[TBL] [Abstract][Full Text] [Related]
33. Cell biology of antigen processing in vitro and in vivo.
Trombetta ES; Mellman I
Annu Rev Immunol; 2005; 23():975-1028. PubMed ID: 15771591
[TBL] [Abstract][Full Text] [Related]
34. Antigen loading of MHC class I molecules in the endocytic tract.
Kleijmeer MJ; Escola JM; UytdeHaag FG; Jakobson E; Griffith JM; Osterhaus AD; Stoorvogel W; Melief CJ; Rabouille C; Geuze HJ
Traffic; 2001 Feb; 2(2):124-37. PubMed ID: 11247303
[TBL] [Abstract][Full Text] [Related]
35. Class II antigen processing: analysis of compartments and functions.
Harding CV
Crit Rev Immunol; 1996; 16(1):13-29. PubMed ID: 8809471
[TBL] [Abstract][Full Text] [Related]
36. Macrophages present pinocytosed exogenous antigen via MHC class I whereas antigen ingested by receptor-mediated endocytosis is presented via MHC class II.
Peppelenbosch MP; DeSmedt M; Pynaert G; van Deventer SJ; Grooten J
J Immunol; 2000 Aug; 165(4):1984-91. PubMed ID: 10925281
[TBL] [Abstract][Full Text] [Related]
37. LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens.
Crotzer VL; Glosson N; Zhou D; Nishino I; Blum JS
Immunology; 2010 Nov; 131(3):318-30. PubMed ID: 20518820
[TBL] [Abstract][Full Text] [Related]
38. Antigen presentation by MHC class II molecules.
Weenink SM; Gautam AM
Immunol Cell Biol; 1997 Feb; 75(1):69-81. PubMed ID: 9046437
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein-mediated pathways of lipid antigen presentation.
van den Elzen P; Garg S; León L; Brigl M; Leadbetter EA; Gumperz JE; Dascher CC; Cheng TY; Sacks FM; Illarionov PA; Besra GS; Kent SC; Moody DB; Brenner MB
Nature; 2005 Oct; 437(7060):906-10. PubMed ID: 16208376
[TBL] [Abstract][Full Text] [Related]
40. Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments.
Bonifaz LC; Arzate S; Moreno J
Eur J Immunol; 1999 Jan; 29(1):119-31. PubMed ID: 9933093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
